{"id":6433,"date":"2024-07-24T14:31:35","date_gmt":"2024-07-24T13:31:35","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/?post_type=pipelines&p=6433"},"modified":"2024-07-29T12:08:16","modified_gmt":"2024-07-29T11:08:16","slug":"bgb-21447-bcl2-inhibitor","status":"publish","type":"pipelines","link":"https:\/\/beonemedaffairs.com\/begenius\/pipelines\/6433\/bgb-21447-bcl2-inhibitor\/","title":{"rendered":"BGB-21447 | BCL2 inhibitor"},"content":{"rendered":"","protected":false},"template":"","meta":{"_acf_changed":false,"editor_notices":[]},"class_list":["post-6433","pipelines","type-pipelines","status-publish","hentry"],"acf":{"indications_repeater":[{"indication":" B-cell malignancies","disease_state":null,"phase":1,"countries":[],"status":false}],"cancer_type":["190"],"compound_type":null,"custom_link":null},"_links":{"self":[{"href":"https:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/pipelines\/6433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/pipelines"}],"about":[{"href":"https:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/types\/pipelines"}],"wp:attachment":[{"href":"https:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/media?parent=6433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}